|
1
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pang RW, Joh JW, Johnson PJ, Monden M,
Pawlik TM and Poon RT: Biology of hepatocellular carcinoma. Ann
Surg Oncol. 15:962–971. 2008. View Article : Google Scholar
|
|
3
|
O’Neil BH and Venook AP: Hepatocellular
carcinoma: the role of the North American GI Steering Committee
Hepatobiliary Task Force and the advent of effective drug therapy.
Oncologist. 12:1425–1432. 2007.PubMed/NCBI
|
|
4
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu L, Wu J, Ying Z, Chen B, Han A, Liang
Y, Song L, Yuan J, Li J and Li M: Astrocyte elevated gene-1
upregulates matrix metalloproteinase-9 and induces human glioma
invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kikuno N, Shiina H, Urakami S, Kawamoto K,
Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M and Dahiya
R: Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer
progression through upregulation of FOXO3a activity. Oncogene.
26:7647–7655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoo BK, Emdad L, Su ZZ, Villanueva A,
Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet
JM, et al: Astrocyte elevated gene-1 regulates hepatocellular
carcinoma development and progression. J Clin Invest. 119:465–477.
2009. View
Article : Google Scholar
|
|
8
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar
|
|
9
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar
|
|
10
|
Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky
DJ and Fisher PB: Cloning and characterization of HIV-1-inducible
astrocyte elevated gene-1, AEG-1. Gene. 353:8–15. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Meng F, Yamagiwa Y, Taffetani S, Han J and
Patel T: IL-6 activates serum and glucocorticoid kinase via
p38alpha mitogen-activated protein kinase pathway. Am J Physiol
Cell Physiol. 289:C971–C981. 2005. View Article : Google Scholar
|
|
12
|
Kobayashi S, Werneburg NW, Bronk SF,
Kaufmann SH and Gores GJ: Interleukin-6 contributes to Mcl-1
up-regulation and TRAIL resistance via an Akt-signaling pathway in
cholangiocarcinoma cells. Gastroenterology. 128:2054–2065. 2005.
View Article : Google Scholar
|
|
13
|
Tilg H, Wilmer A, Vogel W, Herold M,
Nölchen B, Judmaier G and Huber C: Serum levels of cytokines in
chronic liver diseases. Gastroenterology. 103:264–274. 1992.
|
|
14
|
Matzaraki V, Alexandraki KI, Venetsanou K,
Piperi C, Myrianthefs P, Malamos N, Giannakakis T, Karatzas S,
Diamanti-Kandarakis E and Baltopoulos G: Evaluation of serum
procalcitonin and interleukin-6 levels as markers of liver
metastasis. Clin Biochem. 40:336–342. 2007. View Article : Google Scholar
|
|
15
|
Johnson C, Han Y, Hughart N, McCarra J,
Alpini G and Meng F: Interleukin-6 and its receptor, key players in
hepatobiliary inflammation and cancer. Transl Gastrointest Cancer.
1:58–70. 2012.
|
|
16
|
Srivastava J, Siddiq A, Emdad L, et al:
Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel
insights from a mouse model. Hepatology. 56:1782–1791. 2012.
View Article : Google Scholar
|
|
17
|
Sarkar D: AEG-1/MTDH/LYRIC in liver
cancer. Adv Cancer Res. 120:193–221. 2013. View Article : Google Scholar
|
|
18
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Leonardi GC, Candido S, Cervello M,
Nicolosi D, Raiti F, Travali S, Spandidos DA and Libra M: The tumor
microenvironment in hepatocellular carcinoma (review). Int J Oncol.
40:1733–1747. 2012.
|
|
20
|
Walter M, Liang S, Ghosh S, Hornsby PJ and
Li R: Interleukin 6 secreted from adipose stromal cells promotes
migration and invasion of breast cancer cells. Oncogene.
28:2745–2755. 2009. View Article : Google Scholar
|
|
21
|
Lin MT, Lin BR, Chang CC, Chu CY, Su HJ,
Chen ST, Jeng YM and Kuo ML: IL-6 induces AGS gastric cancer cell
invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Int J Cancer. 120:2600–2608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tu B, Du L, Fan QM, Tang Z and Tang TT:
STAT3 activation by IL-6 from mesenchymal stem cells promotes the
proliferation and metastasis of osteosarcoma. Cancer Lett.
325:80–88. 2012. View Article : Google Scholar
|
|
23
|
Johnston PA and Grandis JR: STAT3
signaling: anticancer strategies and challenges. Mol Interv.
11:18–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu H and Jove R: The STATS of cancer - new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar
|
